Evidence map›Paper›PMID 27179644›Full record

ArticleCytotechnology2016

Cell confluency analysis on microcarriers by micro-flow imaging.

Christopher J Farrell, Stephanie M Cicalese, Harrison B Davis, Belma Dogdas, Tosha Shah, Tim Culp, Van M Hoang

Abstract read
In one paragraph

Article in Cytotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. A Simple Method forBio-protocol · 2021
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher J FarrellVaccine Analytical Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA. christopher.farrell@merck.com.ORCID http://orcid.org/0000-0003-3506-6782
Stephanie M CicaleseEurofins Lancaster Laboratories Professional Scientific Services, Lancaster, PA, USA.
Harrison B DavisVaccine Drug Product Development, Merck & Co., Inc., West Point, PA, USA.
Belma DogdasApplied Mathematics and Modeling, Merck & Co., Inc., Rahway, NJ, USA.
Tosha ShahApplied Mathematics and Modeling, Merck & Co., Inc., Rahway, NJ, USA.
Tim CulpVaccine Analytical Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA.
Van M HoangVaccine Analytical Development, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The productivity of cell culture-derived vaccines grown in anchorage-dependent animal cells is limited by bioreactor surface area. One way to increase the available surface area is by growing cells as monolayers on small spheres called microcarriers, which are approximately 100-250 μm in diameter. In order for microcarrier-based cell culture to be a success, it is important to understand the kinetics of cell growth on the microcarriers. Micro-flow imaging (MFI) is a simple and powerful technique that captures images and analyzes samples as they are drawn through a precision flow cell. In addition to providing size distribution and defect frequency data to compare microcarrier lots, MFI was used to generate hundreds of images to determine cell coverage and confluency on microcarriers. Same-day manual classification of these images provided upstream cell culture teams with actionable data that informed in-process decision making (e.g. time of infection). Additionally, an automated cell coverage algorithm was developed to increase the speed and throughput of the analyses.

Indexed as

ConfluencyMammalian cell cultureMicrocarriersMicro-flow Imaging

Identifiers

PMID27179644
PMCPMC5101317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.